$24.75
+0 (+0%)
At Close: Jun 02, 2026
OpGen's Subsidiary Curetis and FIND Extend R&D Collaboration Agreement
08:00am, Thursday, 03'rd Aug 2023
ROCKVILLE, Md., Aug. 03, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinfor
OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern Time
07:30am, Thursday, 03'rd Aug 2023
ROCKVILLE, Md., Aug. 03, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its second qu
OpGen's Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND
07:30am, Wednesday, 19'th Jul 2023
ROCKVILLE, Md., July 19, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinfor
Buy 5 Top-Ranked Stocks With Rising P/E in July
09:20am, Thursday, 06'th Jul 2023
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include OpGen (OPGN), Adaptimmune Therapeutics (ADAP), Valmont Industries (VMI), Versus Systems (VS) and
Bet on DuPont Analysis to Pick 5 Stocks for Stellar Returns
07:18am, Wednesday, 21'st Jun 2023
Do you have more faith in DuPont analysis than simple ROE calculation? Tap PDD Holdings Inc. (PDD), OpGen (OPGN), AGCO (AGCO), A10 Networks (ATEN) and The Duckhorn Portfolio (NAPA).
Go Beyond Bargain Hunting; Buy 5 Stocks With Rising P/E
09:10am, Monday, 05'th Jun 2023
Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include OpGen (OPGN), The RealReal (REAL), Trevena (TRVN), ChargePoint (CHPT) and Caterpillar (CAT).
Go Beyond Bargain Hunting, Buy 5 Stocks With Rising P/E
08:26am, Thursday, 18'th May 2023
Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include OpGen (OPGN), Horizon Technology Finance (HRZN), Equity Commonwealth (EQC), NOV (NOV) and Spartacus Acq
OpGen Inc. (OPGN) Q1 2023 Earnings Call Transcript
08:19pm, Monday, 15'th May 2023
OpGen Inc. (NASDAQ:OPGN ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Oliver Schacht – President and Chief Executive Officer Albert Weber – Chief Financial Office
Forget Bargain Hunting, Buy 5 Stocks With Rising P/E
08:24am, Tuesday, 18'th Apr 2023
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Disney (DIS), Casey's General Stores (CASY), OpGen (OPGN), Accelerate Diagnostics (AXDX) and Nekt
OpGen, Inc. (OPGN) Q4 2022 Earnings Call Transcript
06:22pm, Wednesday, 29'th Mar 2023
OpGen, Inc. (NASDAQ:OPGN ) Q4 2022 Earnings Conference Call March 29, 2023 4:30 PM ET Company Participants Oliver Schacht - President and CEO Albert Weber - CFO Conference Call Participants Nidhi Sing
Penny Stocks To Buy Now? 7 To Watch With Big News this Week
09:28am, Thursday, 26'th Jan 2023
Penny stocks with news that has turned heads in the stock market this week. The post Penny Stocks To Buy Now?
The Impact of Market Trends on Penny Stocks Trading
06:00am, Wednesday, 14'th Dec 2022
How to use market trends to make money with penny stocks The post The Impact of Market Trends on Penny Stocks Trading appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks
Why Are Stocks Up Today?
02:00pm, Tuesday, 13'th Dec 2022
Investors wondering why stocks are up today have to look no further as the Consumer Price Index data for November 2022 is behind the rise. The big data that has traders celebrating today is inflation
Why Is OpGen (OPGN) Stock Up 148% Today?
01:23pm, Tuesday, 13'th Dec 2022
OpGen (NASDAQ: OPGN ) stock is rocketing higher on Tuesday after posting results from its Unyvero urinary tract infections ( UTI ) clinical trial. This clinical trial covered Unyvero UTI Panel's abili
OpGen, Inc. (OPGN) Q3 2022 Earnings Call Transcript
11:29pm, Thursday, 10'th Nov 2022
OpGen, Inc. (NASDAQ:OPGN ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Alyssa Factor - Investor Relations Associate, Edison Group Oliver Schacht - President & Ch
Sign In
Buy OPGN